Clinical Trial Update: Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211) [Phase 3]

View source ↗

Summary

Phase 3 trial ANRS 1211 evaluating pegylated interferon plus ribavirin for treatment-naive chronic hepatitis C in Egyptian patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED